Insmed Incorporated - Common Stock (INSM) stock analysis
INSM · Insmed Incorporated - Common Stock
Latest recorded price: USD 122.88
Sector and industry: Healthcare · Biotechnology
Fiscal 2025 figures: revenue growth 35.2%, free cash flow margin -159.6%, ROIC -708.0%. The model flags 1 risk signal for this company (1 high severity).
Similar companies in Healthcare
- Innoviva, Inc. (INVA)
- Ionis Pharmaceuticals, Inc. (IONS)
- Iovance Biotherapeutics, Inc. (IOVA)
- Jazz Pharmaceuticals plc - Ordinary Shares (JAZZ)
- Korsana Biosciences, Inc. (KRSA)
- Krystal Biotech, Inc. - Common Stock (KRYS)
- Kymera Therapeutics, Inc. - Common Stock (KYMR)
- Ligand Pharmaceuticals Incorporated - Common Stock (LGND)